Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety

Efgartigimod is associated with clinical benefit in patients with VLOGMG, allowing corticosteroid reduction without compromising comorbidity stability. Early initiation may enable faster disease control and more durable responses.

Authors

Benqiao Wang
Ruixia Zhu
Chi Ma
Jingyi Shen (ORCID: https://orcid.org/0009-0003-8677-4823)
Ying Zhu

Institutions

First Hospital of China Medical University (CN)
China Medical University (CN)

Publication Details

Journal: Current Neuropharmacology
Published: 2026-01-13
DOI: https://doi.org/10.2174/011570159x415163251205123550
Primary Topic: Myasthenia Gravis and Thymoma
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety

Benqiao Wang, Ruixia Zhu, Chi Ma, Jingyi Shen et al.

Jan 13, 2026

Current Neuropharmacology

Myasthenia Gravis and Thymoma

article

Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety

Benqiao Wang, Ruixia Zhu, Chi Ma, Jingyi Shen, Ying Zhu

January 13, 2026article en

Abstract

Current NeuropharmacologyVol. 24

First Hospital of China Medical University (CN), China Medical University (CN)

Openalex Percentile: Top 81%

Myasthenia Gravis and Thymoma

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.